Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1955 1
1958 1
1963 1
1964 1
1968 1
1969 1
1970 3
1972 2
1975 1
1977 1
1978 1
1980 1
1983 1
1985 2
1986 2
1987 1
1988 1
1991 2
1992 3
1993 3
1994 5
1995 8
1996 5
1997 8
1998 1
1999 1
2000 3
2001 2
2002 6
2003 3
2004 4
2005 1
2006 6
2007 10
2008 13
2009 7
2010 10
2011 4
2012 6
2013 9
2014 11
2015 15
2016 13
2017 15
2018 15
2019 11
2020 18
2021 14
2022 13
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: sur r. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Editorial comment.
Sur RL. Sur RL. J Urol. 2012 Mar;187(3):924. doi: 10.1016/j.juro.2011.10.183. Epub 2012 Jan 20. J Urol. 2012. PMID: 22264466 No abstract available.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: sur rk. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
Editorial Comment.
Sur RL. Sur RL. J Urol. 2021 Sep;206(3):537. doi: 10.1097/JU.0000000000001836.02. Epub 2021 Jun 16. J Urol. 2021. PMID: 34132605 No abstract available.
Editorial Comment.
Sur RL. Sur RL. J Urol. 2018 Apr;199(4):1014. doi: 10.1016/j.juro.2017.10.057. Epub 2017 Dec 24. J Urol. 2018. PMID: 29276948 No abstract available.
254 results